Skip to content

CONTOUR® NEXT 7278Recalls & reported problems

Ascensia Diabetes Care US Inc. · Blood Glucose Test Strips - 35 Test Strips (per bottle) - sold in a carton of 2 bottles (70 test strips total). · Class 2

Quick summary

This CONTOUR NEXT blood glucose test strip is used to measure blood sugar. The 24 reports mostly describe readings that appear inaccurate or unusually high or low, along with opened or broken packaging; 3 mention injuries and there were no deaths. No recalls name this device, and reports fell from 4 in the previous 12 months to 0 in the latest 12 months.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
24
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 24 adverse event reports that list this exact device (DI 10301937278706), received between Apr 16, 2018 and Oct 17, 2025 — classified as 3 injuries, 21 malfunctions.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (10 reports).

23 other recalls cover devices cleared under the same FDA submission (K121190, K160430, K162336, K191286, K193407, K210687, K223293, K241787, P150001, P160017); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings10
  • High Readings8
  • Unsealed Device Packaging4
  • Low Readings2

Patient problems

  • No Clinical Signs, Symptoms or Conditions15
  • No Known Impact Or Consequence To Patient4
  • Dizziness3
  • Hypoglycemia1
  • Loss of consciousness1
  • Weakness1

Recent adverse event reports

The 24 most recent of 24 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 17, 2025High Readings; High Readings

    THE CUSTOMER RETURNED THE SUSPECTED CONTOUR® NEXT EZ METER FOR EVALUATION. A REVIEW OF THE METER'S LOGBOOK SHOWED THE FOLLOWING BLOOD GLUCOSE READINGS RECORDED ON THE DATE OF THE EVENT (B)(6) 2025): 171 MG/DL AT 11:27 A.M., 115 MG/DL AT 12:25 P.M., 43 MG/DL AT 1:37 P.M., 110 MG/DL AT 7:59 P.M., 86 MG/DL AT 9:08 P.M., AND 60 MG/DL AT 11:29 P.M.

    Patient problems: Dizziness

    MAUDE report 23324187 ↗
  • MalfunctionJul 8, 2025High Readings; High Readings

    THE CUSTOMER REPORTED THAT AT APPROXIMATELY 2:30 P.M., SHE OBTAINED BLOOD GLUCOSE READINGS OF 103 MG/DL WITH THE CONTOUR® NEXT GEN METER AND 58 MG/DL WITH THE LABORATORY TESTING. THE CUSTOMER STATED THAT SHE WAS FEELING DIZZY AND CONSUMED FOOD, HOWEVER, SHE DID NOT ASSOCIATE THE SYMPTOM WITH HYPOGLYCEMIA. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: Dizziness

    MAUDE report 22436761 ↗
  • MalfunctionJun 3, 2025Unsealed Device Packaging; Unsealed Device Packaging

    THE CUSTOMER REPORTED THAT UPON OPENING A BOX OF CONTOUR® NEXT TEST STRIPS, SHE DISCOVERED THAT THE VIAL AND CAP OF THE TEST STRIPS INSIDE WERE BROKEN AND THE CAP WAS ALREADY OPEN. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22133914 ↗
  • MalfunctionMar 7, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER RAN A BLOOD GLUCOSE TEST WITH THE CONTOUR® NEXT GEN METER AND OBTAINED A READING OF 183 MG/DL AT 7:27 A.M. THE METER AUTOMATICALLY MARKED IT AS A CONTROL TEST, AND SO THE READING WILL BE DISPLAYED AS A CONTROL RESULT WHEN ACCESSING THE METER'S MEMORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21548524 ↗
  • MalfunctionOct 23, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER REPORTED THAT HE PERFORMED A BLOOD GLUCOSE TESTING WITH THE CONTOUR NEXT ONE METER AT 4:42 P.M. AND OBTAINED A READING 36 MG/DL. THE METER AUTOMATICALLY MARKED IT AS A CONTROL TEST, AND SO THE READING WILL BE DISPLAYED AS A CONTROL RESULT WHEN ACCESSING THE METER'S MEMORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20513929 ↗
  • MalfunctionNov 10, 2023Unsealed Device Packaging; Unsealed Device Packaging

    THE CUSTOMER REPORTED THAT HE OPENED A BOX OF THE CONTOUR NEXT TEST STRIPS AND THE BOTTLE WAS ALREADY OPEN. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. A REPLACEMENT METER KIT WAS SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18111073 ↗
  • MalfunctionSep 1, 2022Low Readings; Low Readings

    THE CUSTOMER REPORTED THAT SHE PERFORMED BLOOD GLUCOSE TESTING WITH THE CONTOUR NEXT METER AND OBTAINED READINGS OF 20 MG/DL AT 7:48 A.M., 33 MG/DL AT 7:49 A.M. AND 92 MG/DL AT 7:55 A.M. THE CUSTOMER DID NOT EXPERIENCE ANY SYMPTOMS OF HYPOGLYCEMIA. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15335782 ↗
  • MalfunctionJun 1, 2022High Readings; High Readings

    THE CUSTOMER REPORTED THAT WITHIN ONE MINUTE SHE OBTAINED BLOOD GLUCOSE READINGS OF 600 MG/DL AND 139 MG/DL WITH THE CONTOUR NEXT ONE METER. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14564719 ↗
  • MalfunctionMay 18, 2022Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER PERFORMED A BLOOD GLUCOSE TESTING WITH THE CONTOUR NEXT LINK 2.4 METER AND OBTAINED A READING OF 43 MG/DL AT 1:00 P.M. THE METER AUTOMATICALLY MARKED IT AS A CONTROL TEST, AND SO THE READING WILL BE DISPLAYED AS A CONTROL RESULT WHEN ACCESSING THE METER'S MEMORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. A REPLACEMENT METER KIT WAS SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14428404 ↗
  • MalfunctionMar 21, 2022Unsealed Device Packaging; Unsealed Device Packaging

    THE CUSTOMER REPORTED THAT HE OPENED A BOX OF THE CONTOUR NEXT TEST STRIPS AND THE BOTTLE WAS ALREADY OPEN. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13839659 ↗
  • MalfunctionMar 15, 2022Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER REPORTED THAT HE PERFORMED BLOOD GLUCOSE TESTING WITH THE CONTOUR NEXT EZ METER AND OBTAINED READINGS OF 138 MG/DL AT 10:03 A.M. AND 142 MG/DL AT 10:06 A.M. THE METER AUTOMATICALLY MARKED THEM AS CONTROL TESTS, AND SO THE READINGS WILL BE DISPLAYED AS CONTROL RESULTS WHEN ACCESSING THE METER'S MEMORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13770850 ↗
  • MalfunctionFeb 10, 2022High Readings; High Readings

    THE CUSTOMER REPORTED THAT SHE OBTAINED BLOOD GLUCOSE READINGS OF 121 MG/DL AND 386 MG/DL AT 6:25 A.M. WITH THE CONTOUR NEXT ONE METER. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13505609 ↗
  • MalfunctionNov 10, 2021High Readings; High Readings

    THE CUSTOMER REPORTED THAT SHE OBTAINED BLOOD GLUCOSE READINGS OF 72 MG/DL AT 10:27 A.M. WITH THE CONTOUR NEXT ONE METER AND 42 MG/DL AT 10:32 A.M. WITH THE LABORATORY TESTING. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. A REPLACEMENT METER KIT WAS SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12788428 ↗
  • MalfunctionOct 1, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER REPORTED THAT SHE OBTAINED BLOOD GLUCOSE READINGS OF 67 MG/DL AT 6:06 P.M. AND 433 MG/DL AT 6:09 P.M. WITH THE CONTOUR NEXT ONE METER. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. A REPLACEMENT METER KIT WAS SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12561793 ↗
  • MalfunctionJan 21, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER REPORTED THAT WHILE HE WAS AT THE PHYSICIAN'S OFFICE, WITHIN 10 MINUTES HE PERFORMED A COMPARISON OF BLOOD GLUCOSE READINGS BETWEEN THE CONTOUR NEXT METER AND AN ALTERNATE METER AND RECEIVED A DIFFERENCE OF 40 MG/DL. NO SPECIFIC READINGS WERE PROVIDED. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT ALLEGED. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. A REPLACEMENT METER KIT WAS SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11207004 ↗
  • MalfunctionOct 1, 2020Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER REPORTED THAT SHE PERFORMED BLOOD GLUCOSE TESTING WITH HER CONTOUR NEXT METER AND OBTAINED A READING OF 20 MG/DL AT 9:21 A.M. THE METER AUTOMATICALLY MARKED IT AS A CONTROL TEST, AND SO THE READING WILL BE DISPLAYED AS A CONTROL RESULT WHEN ACCESSING THE METER'S MEMORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 10612158 ↗
  • MalfunctionOct 1, 2020Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER REPORTED THAT SHE PERFORMED BLOOD GLUCOSE TESTING WITH HER CONTOUR NEXT METER AND OBTAINED A READING OF 45 MG/DL AT 8:12 A.M. THE METER AUTOMATICALLY MARKED IT AS A CONTROL TEST, AND SO THE READING WILL BE DISPLAYED AS A CONTROL RESULT WHEN ACCESSING THE METER'S MEMORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT METER KIT AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 10612156 ↗
  • MalfunctionAug 10, 2020Unsealed Device Packaging; Unsealed Device Packaging

    THE CUSTOMER REPORTED THAT TWO BOTTLES OF CONTOUR NEXT TEST STRIPS WERE ALREADY OPEN. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE FOR EVALUATION. REPLACEMENT TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 10384640 ↗
  • InjuryMar 4, 2020High Readings; High Readings

    THE CUSTOMER REPORTED THAT ON (B)(6) 2020, SHE OBTAINED A BLOOD GLUCOSE READING OF 577 MG/DL ON THE CONTOUR NEXT METER AT 11:57 P.M. BASED ON THIS READING, THE CUSTOMER TOOK 8 UNITS OF HUMALOG INSULIN AND 10 UNITS OF LANTUS INSULIN, WHICH IS LOWER THAN HER PRESCRIBED DOSE OF 20 UNITS OF LANTUS. THE NEXT DAY CUSTOMER BECAME UNCONSCIOUS. THE PARAMEDICS WERE CALLED AND THEY PERFORMED TESTING USING THE CUSTOMER'S CONTOUR NEXT METER, WHICH GAVE A READING OF 34 MG/DL AT 10:05 A.M. THE CUSTOMER RECEIVED ORANGE JUICE, POP SODA AND PEANUT BUTTER SANDWICH, AFTER WHICH SHE RECOVERED WELL. THE CUSTOMER WAS ADVISED TO RETURN THE DEVICE OF EVALUATION. REPLACEMENT METER AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: Loss of consciousness

    MAUDE report 9787328 ↗
  • MalfunctionDec 3, 2019High Readings; High Readings

    THE CUSTOMER REPORTED THAT SHE OBTAINED BLOOD GLUCOSE READINGS OF 314 MG/DL AND 142 MG/DL ON THE CONTOUR NEXT ONE METER, AND 150 MG/DL AND 156 MG/DL ON A NON-ASCENSIA METER. ALL READINGS WERE OBTAINED WITHIN 10 MINUTES. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE TEST STRIPS FOR EVALUATION. REPLACEMENT METER AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9404789 ↗
  • MalfunctionMay 15, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER OBTAINED FOLLOWING BLOOD GLUCOSE READINGS BETWEEN 6:17 P.M. AND 6:27 P.M. ON HER CONTOUR NEXT LINK 2.4 METER: 517 MG/DL, 561 MG/DL, 148 MG/DL, 126 MG/DL, AND 59 MG/DL. THE CUSTOMER STATED THAT SHE WAS EXPERIENCING HYPOGLYCEMIC SYMPTOMS SUCH AS DIZZINESS AND WEAKNESS. THE CUSTOMER DRANK APPLE JUICE. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE TEST STRIPS FOR EVALUATION. REPLACEMENT METER AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: Dizziness; Weakness

    MAUDE report 8612857 ↗
  • MalfunctionFeb 15, 2019Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER RECEIVED A BLOOD GLUCOSE READING ON HIS CONTOUR NEXT ONE METER THAT HAD A DIFFERENCE OF 60 MG/DL WHEN COMPARED WITH ANOTHER METER. THE SPECIFIC READINGS WERE NOT PROVIDED. THERE IS NO ALLEGATION OF ADVERSE EVENT. THE CUSTOMER WAS ADVISED TO RETURN THE TEST STRIPS FOR EVALUATION. REPLACEMENT METER AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8344383 ↗
  • MalfunctionJan 9, 2019Low Readings; Low Readings

    THE CUSTOMER OBTAINED A BLOOD GLUCOSE READING OF 45 MG/DL ON A CONTOUR NEXT ONE METER. UPON REPEAT TESTING WITHIN 5 MINUTES ON A DIFFERENT METER, A READING OF 245 MG/DL WAS OBTAINED. THE CUSTOMER HAD NO SYMPTOMS OF HYPOGLYCEMIA OR HYPERGLYCEMIA. THE DIFFERENCE BETWEEN THE READINGS FALLS IN "C" ZONE OF THE CONSENSUS ERROR GRID, MAKING THE DIFFERENCE CLINICALLY SIGNIFICANT. NO ADVERSE EVENT WAS ALLEGED. THE CUSTOMER WAS ADVISED TO RETURN THE TEST STRIPS FOR EVALUATION. REPLACEMENT METER AND TEST STRIPS WERE SENT TO THE CUSTOMER.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8232225 ↗
  • InjuryApr 16, 2018High Readings; High Readings

    ADVOCATE STATED HIS WIFE RECEIVED HIGH BLOOD GLUCOSE READINGS ON HER CONTOUR NEXT WHEN SHE WAS FEELING LOW SYMPTOMS, BUT BASED ON THE READINGS SHE SELF MEDICATED AND ENDED UP IN THE HOSPITAL. FURTHER INFORMATION WAS NOT PROVIDED. WHEN THE CUSTOMER COMPARED HER READINGS TO THE DOCTOR'S METER, HER METER READ 60MG/DL HIGHER THAN THE DOCTOR'S METER. RESULTS WERE NOT PROVIDED. A 60MG/DL DIFFERENCE BETWEEN READINGS COULD FALL IN THE "C" ZONE OF THE CONSENSUS ERROR GRID, MAKING THE DIFFERENCE CLINICALLY SIGNIFICANT. PRODUCT WAS NOT EXPECTED TO BE RETURNED NOR WAS IT REPLACED.

    Patient problems: Hypoglycemia

    MAUDE report 7432427 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K121190, K160430, K162336, K191286, K193407, K210687, K223293, K241787, P150001, P160017. One submission often covers many models, so check the product and lot details in each record.

  • Z-2981-2026 · Jul 13, 2026 · Open, Classified
    MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
  • Z-1742-2026 · Feb 13, 2026 · Open, Classified
    MiniMed 770G Insulin Pump (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
  • Z-1739-2026 · Feb 13, 2026 · Open, Classified
    MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)
  • Z-1740-2026 · Feb 13, 2026 · Open, Classified
    MiniMed 630G Insulin Pump (MMT-1714, MMT-1715, MMT-1754, MMT-1755)
  • Z-1261-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 670G (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)
  • Z-1266-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 780G (MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896)
  • Z-1265-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 770G (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)
  • Z-1259-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 630G (MMT-1714, MMT-1715, MMT-1754, MMT-1755)
  • Z-0003-2025 · Jul 31, 2024 · Open, Classified
    MiniMed Insulin Pump Device. MiniMed 670G, REF: MMT-1580, MMT-1581, MMT-1582, MMT-1780, MMT-1781, MMT-1782, MMT-1740, MMT-1741, MMT-1742, MMT-1760, MMT-1761, MMT-1762; MiniMed 770G
  • Z-0001-2025 · Jul 31, 2024 · Open, Classified
    MiniMed 630G Insulin Pump, REF: MMT-1515, MMT-1714, MMT-1715, MMT-1754, MMT-1755; MiniMed 700G Insulin Pump, REF: MMT-1800, MMT-1801, MMT-1805, MMT-1850, MMT-1851
  • Z-2211-2023 · May 19, 2023 · Open, Classified
    Contour next GEN Blood Glucose Monitoring System
  • Z-0193-2023 · Sep 20, 2022 · Open, Classified
    Insulin Pump/Model: MiniMed 630G/ MMT-1715, MMT-1755, MMT-1754; MiniMed 670G/ MMT-1780, MMT-1781, MMT-1782, MMT-1760, MMT-1761, MMT-1762, MMT-1740, MMT-1741, MMT-1742
  • Z-0855-2022 · Jan 27, 2022 · Open, Classified
    MiniMed 630G: MMT-1715, MMT-1754, MMT-1755; MiniMed 670G: MMT-1740, MMT-1741, MMT-1742, MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782; MiniMed 770G: MMT-1880, MMT-18
  • Z-1771-2021 · Mar 15, 2021 · Open, Classified
    MiniMed 780G Insulin Pump: Models: PUMP MMT-1885 MM780G 6.5V BLE MMOL; PUMP MMT-1886 MM780G 6.5W BLE MG; KIT MMT-1895WW MM780G 6.5V BLE SF MMOL; KIT MMT-1896WW MM780G 6.5W BLE
  • Z-0516-2021 · Apr 30, 2020 · Open, Classified
    MiniMed 670G, insulin pump, Ref/Model # MMT-1760KPK, MMT-1762KCN, MMT-1762WWK - Product Usage: indicated for continuous or periodic monitoring of glucose levels in the fluid under

…and 8 more.

Other Glucose Dehydrogenase, Glucose devices

All Glucose Dehydrogenase, Glucose devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.